Samjin Pharmaceuticals Co., Ltd.
KRX:005500.KS
18,090 (KRW) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Samjin Pharmaceuticals Co., Ltd. |
Symbool | 005500.KS |
Munteenheid | KRW |
Prijs | 18,210 |
Beurswaarde | 228,123,589,800 |
Dividendpercentage | 4.04% |
52-weken bereik | 17,110 - 23,600 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Yong-Joo Choi |
Website | https://www.samjinpharm.co.kr |
An error occurred while fetching data.
Over Samjin Pharmaceuticals Co., Ltd.
Samjin Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in Korea. The company's products include SA001, a clinical Phase II product for the treatment of dry eye and sjogren syndrome; SJP1803/1804, a preclinical stage product for the treatment of macular degeneration; SJP601 and SJP1602 preclinical stage
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)